uniQure Announces 36 Weeks of Follow-Up Data from Phase IIb Study of AMT-061 and Long-Term Follow-Up Data for AMT-060 in Patients with Hemophilia B July 6, 2019 - NASDAQ Companies 0 » View More News for July 06, 2019